News

The first European-wide genomic survey of gonorrhoea has mapped antibiotic resistance in this sexually transmitted disease throughout the continent. Researchers also showed that using DNA sequencing data they could accurately determine antibiotic resistance and identify incorrect laboratory test results.

Specially arranged nano-sized cellulose fibers are the strongest material of them all, in a move that might cause some to re-name Superman the “man of cellulose.”

Researchers have uncovered important genomic data from the remains of an ancient giant ground sloth. The analysis, they say, proves for the first time that the giant ground sloth—which went extinct approximately 10,000 years ago—is a close relative of the modern two-fingered sloth, believed to be one of the world’s slowest mammals.

Researchers have published the first major results from the American Gut Project , a crowdsourced, global citizen science effort. The project is the largest published study to date of the human microbiome — the unique microbial communities that inhabit our bodies.

Scientists report that beef protein, when broken down into peptides, can block bitter taste receptors on the tongue. Such peptides could someday be used to make other foods and even medicines taste better.

Researchers have discovered a mutation that can protect against Alzheimer’s disease in mice. They found that a specific mutation can reduce the characteristic accumulation of the amyloid-beta peptide that occurs in the nerve cells of Alzheimer's patients.

Research has shed new light on how an increasingly common consumer product component – silver nanoparticles – can potentially interfere with the treatment of wastewater. The findings suggest conventional toxicity testing methods for silver concentrations at treatment plants may produce results that yield a false sense of security.

Researchers have discovered how unusually long strands of RNA, termed “long non-coding RNAs” or lincRNAs, help colon cancer cells avoid death, allowing unregulated growth. A new study showed some lincRNAs could be targeted by drug developers.

Novel cannabinoids could provide new therapy options for patients with drug-resistant epilepsy.

Large-scale clinical trial finds cannabidiol can dramatically reduce the number of dangerous seizures in patients with a severe form of epilepsy called Lennox–Gastaut syndrome.